Literature DB >> 16801601

Risk associated with the metabolic syndrome versus the sum of its individual components.

Johan Sundström1, Erik Vallhagen, Ulf Risérus, Liisa Byberg, Björn Zethelius, Christian Berne, Lars Lind, Erik Ingelsson.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16801601     DOI: 10.2337/dc06-0664

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  22 in total

1.  The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes.

Authors:  Birgitta Grundmark; Hans Garmo; Massimo Loda; Christer Busch; Lars Holmberg; Björn Zethelius
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

2.  Added value of different metabolic syndrome definitions for predicting cardiovascular disease and mortality events among elderly population: Tehran Lipid and Glucose Study.

Authors:  A Mozaffary; M Bozorgmanesh; F Sheikholeslami; F Azizi; F Eskandari; F Hadaegh
Journal:  Eur J Clin Nutr       Date:  2014-05-28       Impact factor: 4.016

Review 3.  Fetal programming and metabolic syndrome.

Authors:  Paolo Rinaudo; Erica Wang
Journal:  Annu Rev Physiol       Date:  2011-09-09       Impact factor: 19.318

4.  Body mass index and body composition measures by dual x-ray absorptiometry in patients aged 10 to 21 years with spinal cord injury.

Authors:  Craig M McDonald; Allison L Abresch-Meyer; Mindy Dopler Nelson; Lana M Widman
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

5.  Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease.

Authors:  Naomi M Hamburg; Martin G Larson; Joseph A Vita; Ramachandran S Vasan; Michelle J Keyes; Michael E Widlansky; Caroline S Fox; Gary F Mitchell; Daniel Levy; James B Meigs; Emelia J Benjamin
Journal:  Am J Cardiol       Date:  2008-01-01       Impact factor: 2.778

6.  Metabolic syndrome, independent of its components, is a risk factor for stroke and death but not for coronary heart disease among hypertensive patients in the ASCOT-BPLA.

Authors:  Ajay K Gupta; Bjorn Dahlof; Peter S Sever; Neil R Poulter
Journal:  Diabetes Care       Date:  2010-04-22       Impact factor: 19.112

Review 7.  The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus.

Authors:  Henry N Ginsberg; Paul R MacCallum
Journal:  J Cardiometab Syndr       Date:  2009

Review 8.  Do statins reduce events in patients with metabolic syndrome?

Authors:  Sarah P Towne; Eddie Thara
Journal:  Curr Atheroscler Rep       Date:  2008-02       Impact factor: 5.113

9.  Presence of metabolic syndrome in football linemen.

Authors:  Jackie L Buell; Doug Calland; Fiona Hanks; Bruce Johnston; Benjamin Pester; Robert Sweeney; Robert Thorne
Journal:  J Athl Train       Date:  2008 Oct-Dec       Impact factor: 2.860

Review 10.  Perturbed autonomic nervous system function in metabolic syndrome.

Authors:  Nicholas Tentolouris; Georgia Argyrakopoulou; Nicholas Katsilambros
Journal:  Neuromolecular Med       Date:  2008-01-26       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.